Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3KEC

Crystal Structure of Human MMP-13 complexed with a phenyl-2H-tetrazole compound

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsAPS BEAMLINE 17-ID
Synchrotron siteAPS
Beamline17-ID
Temperature [K]110
Detector technologyCCD
Collection date2001-09-28
DetectorMAR CCD 165 mm
Wavelength(s)1.0
Spacegroup nameP 21 21 2
Unit cell lengths133.209, 72.348, 36.356
Unit cell angles90.00, 90.00, 90.00
Refinement procedure
Resolution50.000 - 2.050
R-factor0.17033
Rwork0.169
R-free0.20357
Structure solution methodFOURIER SYNTHESIS
RMSD bond length0.008
RMSD bond angle1.067
Data reduction softwareHKL-2000
Data scaling softwareHKL-2000
Phasing softwareAMoRE
Refinement softwareREFMAC (5.2.0019)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]50.0002.110
High resolution limit [Å]2.0402.040
Rmerge0.0670.136
Number of reflections19429
<I/σ(I)>13.45.8
Completeness [%]100.088
Redundancy2.62.6
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, SITTING DROP8277Protein: 5.5 mg/ml MMP-13 with 200 uM surrogate inhibitor in 20mM Tris pH 8.5 and 5 mM CaCl2 reservoir: 1.1-1.6M Li2SO4 in 0.1M Hepes pH 7.4-8.2 drop ratio: 5ul protein + 1 ul reservoir, Vapor diffusion, sitting drop, temperature 277K

219869

PDB entries from 2024-05-15

PDB statisticsPDBj update infoContact PDBjnumon